NCT05274373|Unknown
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
COVISERA
Loading search results
COVISERA
Sponsor study identifier
observational
47
1 country
1
Study Start
May 24, 2020
Actual (reported)Primary Completion
May 5, 2021
Actual (reported)Study Completion
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Assessment of the association between the severity of COVID-19 and SARS-CoV-2 NAb titers levels for up to six months following primary infection using a live virus NAb assay. Description of SARS-CoV-2 viral shedding and infectiousness during the first 30 days after infection in a group of unvaccinated hospitalized patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 24, 2020
Actual (reported)May 5, 2021
Actual (reported)March 8, 2022
Actual (reported)March 10, 2022
Actual (reported)October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Neutralizing Antibody Titer - Day 0
Baseline Log10 Spike protein neutralizing antibody titer
Day 0
Change from baseline in Neutralizing Antibody Titer - Day 30
Log10 Spike protein neutralizing antibody titer
Day 30
Change from baseline in Neutralizing Antibody Titer - Day 90
Log10 Spike protein neutralizing antibody titer
Day 90
Change from baseline in Neutralizing Antibody Titer- Day 180
Log10 Spike protein neutralizing antibody titer
Day 180
Baseline Viral Load - Day 0
Day 0
Change from Baseline Viral Load - Day 3
Day 3
Change from Baseline Viral Load - Day 7
Day 7
Change from Baseline Viral Load - Day 10
Day 10
Change from Baseline Viral Load - Day 14
Day 14
Adult unvaccinated hospitalized patients
Copenhagen University Hospital at North Zealand
Copenhagen, 25482, Denmark
Sejdic A, Frische A, Jorgensen CS, Rasmussen LD, Trebbien R, Dungu A, Holler JG, Ostrowski SR, Eriksson R, Soborg C, Nielsen TL, Fischer TK, Lindegaard B, Franck KT, Harboe ZB. High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients. Virol J. 2023 Jan 25;20(1):14. doi: 10.1186/s12985-023-01974-8.
1. Oropharyngeal swabs 2. Serum
Zitta Barrella Harboe, MD, PhD
Nordsjaellands Hospital
47 participants (actual enrollment reported by the registry).
First Submitted
March 8, 2022
First Posted
March 10, 2022
Study Start
May 24, 2020
Actual (reported)Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above
Viral culturing - Day 0
Number of successful viral culturing attempts (SARS-CoV-2)
Day 0
Viral culturing - Day 3
Number of successful viral culturing attempts (SARS-CoV-2)
Day 3
Viral culturing - Day 7
Number of successful viral culturing attempts (SARS-CoV-2)
Day 7
Viral culturing - Day 10
Number of successful viral culturing attempts (SARS-CoV-2)
Day 10
Viral culturing - Day 14
Number of successful viral culturing attempts (SARS-CoV-2)
Day 14
Viral culturing - Day 17
Number of successful viral culturing attempts (SARS-CoV-2)
Day 17
Viral culturing - Day 24
Number of successful viral culturing attempts (SARS-CoV-2)
Day 24
Viral culturing - Day 30
Number of successful viral culturing attempts (SARS-CoV-2)
Day 30
Contact the study team to confirm eligibility.
Primary Completion
May 5, 2021
Actual (reported)Study Completion
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 10, 2022
Record last verified: 2022-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: